SCHEMBL21704601

SCHEMBL21704601

CCC(=O)[C@H](N)CO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8778788 1.00
SCHEMBL4426079 1.00
Hydrochloric Acid SCHEMBL15468113 0.97
SCHEMBL9745347 0.80 METAP1 (0.38)
SCHEMBL12280967 0.80
SCHEMBL12462672 0.80
SCHEMBL12280642 0.80
SCHEMBL10031747 0.79
SCHEMBL10067943 0.78
Hydrochloric Acid SCHEMBL9548897 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023086557-A1 NUCLEOSIDES FOR THE TREATMENT OF DNA VIRUS INFECTIONS EMORY UNIVERSITY (US) 2023-05-19 WO disclosed
US-20200048228-A1 ALVOCIDIB PRODRUGS AND THEIR USE AS PROTEIN KINASE INHIBITORS SUMITOMO PHARMA ONCOLOGY, INC. 2020-02-13 US disclosed